Clinical trial
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating…
NCT00134030 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00134030 |
|---|---|
| Title | Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma |
| Official title | A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-operative Chemotherapy |
| Acronym | EURAMOS-1 |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH University College, London Medical Research Council |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Localized Osteosarcoma, Metastatic Osteosarcoma |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | Cisplatin, Doxorubicin Hydrochloride, Etoposide, Ifosfamide, Methotrexate, Peginterferon Alfa-2b, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery |
| Enrollment | 1,334 |
| Start date | Nov 14, 2005 |
| Primary completion | Jan 31, 2015 |
| Completion | Sep 30, 2022 |
| First posted | Aug 24, 2005 |
| Last update posted | Jun 7, 2023 |
| Countries | Australia, Canada, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: